- Home
- BIYA vs SNSE Comparison
BIYA vs SNSE Comparison
Compare BIYA & SNSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIYA
- SNSE
- Stock Information
- Founded
- BIYA 2017
- SNSE 2005
- Country
- BIYA China
- SNSE United States
- Employees
- BIYA N/A
- SNSE N/A
- Industry
- BIYA
- SNSE Biotechnology: Pharmaceutical Preparations
- Sector
- BIYA
- SNSE Health Care
- Exchange
- BIYA NYSE
- SNSE Nasdaq
- Market Cap
- BIYA 7.8M
- SNSE 9.3M
- IPO Year
- BIYA 2025
- SNSE 2021
- Fundamental
- Price
- BIYA $0.75
- SNSE $9.27
- Analyst Decision
- BIYA
- SNSE Strong Buy
- Analyst Count
- BIYA 0
- SNSE 3
- Target Price
- BIYA N/A
- SNSE $86.67
- AVG Volume (30 Days)
- BIYA 3.1M
- SNSE 13.5K
- Earning Date
- BIYA 05-13-2025
- SNSE 08-05-2025
- Dividend Yield
- BIYA N/A
- SNSE N/A
- EPS Growth
- BIYA N/A
- SNSE N/A
- EPS
- BIYA N/A
- SNSE N/A
- Revenue
- BIYA $12,809,211.00
- SNSE N/A
- Revenue This Year
- BIYA N/A
- SNSE N/A
- Revenue Next Year
- BIYA N/A
- SNSE N/A
- P/E Ratio
- BIYA N/A
- SNSE N/A
- Revenue Growth
- BIYA 10.66
- SNSE N/A
- 52 Week Low
- BIYA $0.59
- SNSE $5.00
- 52 Week High
- BIYA $8.00
- SNSE $17.40
- Technical
- Relative Strength Index (RSI)
- BIYA N/A
- SNSE 70.29
- Support Level
- BIYA N/A
- SNSE $7.62
- Resistance Level
- BIYA N/A
- SNSE $8.98
- Average True Range (ATR)
- BIYA 0.00
- SNSE 0.70
- MACD
- BIYA 0.00
- SNSE 0.22
- Stochastic Oscillator
- BIYA 0.00
- SNSE 98.52
About BIYA BAIYA INTERNATIONAL GROUP INC
Baiya International Group Inc is a company which operates through its subsidiary Gongwuyuan operates a cloud-based internet platform to provide one-stop crowdsourcing recruitment and SaaS-enabled HR solutions in the flexible employment marketplace. The Company's business is focused around on four primary services which are job matching services, entrusted recruitment services, project outsourcing services and abor dispatching services in the flexible employment market within China, mainly in the core manufacturing regions including the Pearl River Delta and Yangtze River Delta region.
About SNSE Sensei Biotherapeutics Inc.
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).